The Times of India

Meet Surbhi Sarna: Indian-origin founder who built a $275 million cancer detection startup after her teenage health struggles

Teenage health struggles inspired Surbhi Sarna to revolutionize ovarian cancer detection. Her startup, nVision Medical, developed a minimally invasive device targeting fallopian tubes, a key origin point for many cancers. This innovation, validated by the FDA, led to a $275 million acquisition by Boston Scientific, offering new hope for early diagnosis and improved survival rates for women globally.